Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while...

from NDTV News - Topstories https://ift.tt/35BsWI9
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Apple, Google Offer 'Nudify' Apps Despite Policies Against Them

Searching for terms like "nudify" and "undress" in the Apple and Google app download stores gives customers access to so...